Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-b)indoles
Authors:
- Ankita MisraAMAnkita Misra
- Imran A. KhanIKImran A. Khan
- Stuti GaurSGStuti Gaur
- Manish JainMJManish Jain
- Surendra SinghSSSurendra Singh
- Madhu DikshitMDMadhu Dikshit
- Anil K. SaxenaASAnil K. Saxena
- 20 December 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (1) , 322-337
Abstract
The development of small molecule inhibitors targeting GPVI has promising therapeutic role, as they inhibit arterial thrombosis with limited risk of bleeding. Among the compounds showing in vivo antithrombotic activity, the most active compound 6b (ED50 = 28.36 μmol/kg po in mice) showed improved inhibition for collagen (IC50 = 6.7 μM), CRP-XL (IC50 = 53.5 μM), and convulxin (CVX) (IC50 = 5.7 μM) mediated platelet aggregation as compared to losartan (LOS) (collagen, IC50 = 10.4 μM; CRP-XL, IC50 = 158 μM; CVX, IC50 = 11 μM) than any of its enantiomers S (6c) (collagen, IC50 = 25.3 μM; CRP-XL, IC50 = 181.4 μM; CVX, IC50 = 9 μM) and R (6d) (collagen, IC50 = 126.3 μM; CRP-XL, IC50 > 500 μM; CVX, IC50 = 86.8 μM). Compound 6b also inhibited platelet P-selectin expression and thus may diminish atherosclerosis. The molecular interactions of both enantiomers 6c and 6d at the GPVI receptor have been explained through docking studies.Keywords
Funding Information
- Council of Scientific and Industrial Research
This publication has 52 references indexed in Scilit:
- Platelet‐bound P‐selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti‐platelet medicationJournal of Thrombosis and Haemostasis, 2010
- Expression of platelet glycoprotein VI is associated with transient ischemic attack and strokeEuropean Journal of Neurology, 2009
- Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivoBasic Research in Cardiology, 2008
- The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) scoreJournal of Thrombosis and Haemostasis, 2007
- Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VIBlood, 2006
- Snake venom C-type lectins interacting with platelet receptors. Structure–function relationships and effects on haemostasisToxicon, 2005
- The role of collagen in thrombosis and hemostasisJournal of Thrombosis and Haemostasis, 2004
- Platelet-collagen interaction: is GPVI the central receptor?Blood, 2003
- The Use of Snake Venom Toxins as Tools to Study Platelet Receptors for Collagen and von Willebrand FactorPathophysiology of Haemostasis and Thrombosis, 2001
- Convulxin Binding to Platelet Receptor GPVI: Competition with Collagen Related PeptidesBiochemical and Biophysical Research Communications, 2000